Back To Search Results

Adrenal Crisis

Editor: Jordan M. Jeong Updated: 2/15/2025 6:17:34 PM

Introduction

Adrenal crisis, or Addisonian crisis, is a severe, life-threatening condition characterized by acute adrenal insufficiency. This condition has a substantial mortality rate of 0.5 per 100 patient years and remains a significant cause of death in individuals with adrenal insufficiency.[1] Patients can experience rapid deterioration without timely intervention, resulting in fatal outcomes either at home or shortly after hospital admission.

This endocrine emergency arises when the production of cortisol, the primary glucocorticoid (GC) adrenal hormone, is inadequate either due to internal or external factors. Early recognition and immediate intervention are crucial for saving a patient's life and improving survival rates.[2] Clinicians must distinguish between adrenal insufficiency and adrenal crisis, as the latter can be fatal if not treated promptly. Adrenal crisis refers to an episode of acute adrenal insufficiency (which may be primary, secondary, or tertiary) and is a medical emergency. However, chronic, stable primary adrenal insufficiency is called Addison disease, a condition controlled with long-term glucocorticoid therapy. Please see StatPearls' companion review, "Adrenal Insufficiency," for further details on Addison disease. 

Adrenal crisis is characterized as an acute change in physiologic status that starts with nonspecific symptoms of fatigue, weakness, nausea, vomiting, abdominal pain, back pain, diarrhea, dizziness, hypotension, and syncope, that quickly progresses to obtundation, metabolic encephalopathy, and shock. Despite the well-described characteristics of this condition, its recognition can be challenging, resulting in delayed treatment initiation and increased morbidity and mortality rates.[3][4] Essential measures in preventing adrenal crises include educating patients and their families about "sick day" rules, by which they should increase hydrocortisone to 2 to 3 times the normal glucocorticoid dose for 2 to 3 days for minor illnesses and more for major illnesses. Clinicians should also ensure the availability of intramuscular hydrocortisone at home.[5][6]

The ongoing debate among experts in the field has led to a lack of consensus on the definition of adrenal crisis. Several expert reviews have tried to establish definitions of adrenal crisis. Among the numerous descriptions available for this condition, a recent study by Rushworth et al in 2019 posited that an adrenal crisis is defined as an acute deterioration in health status associated with either of the following conditions:

  • Absolute hypotension with a systolic blood pressure <100 mm Hg.
  • Relative hypotension with a systolic blood pressure at least 20 mm Hg lower than the patient's usual baseline [3]

Typically, these features should improve and resolve within 1 to 2 hours after administering parenteral glucocorticoids, marked by a significant reduction in hypotension within the first hour. Furthermore, there should be a gradual improvement in patients' clinical symptoms over the subsequent 2 hours.[3]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

History of Adrenal Crisis

In 1855, Thomas Addison's pioneering work provided the earliest description of adrenal insufficiency, marking a significant milestone in comprehending this condition.[7] The discovery of cortisone by Hench, Kendall, and Reichstein in the late 1940s revolutionized the treatment of adrenal insufficiency, leading to a remarkable enhancement in the life expectancy of individuals affected by this condition.[8][9] 

In the 1930s, tuberculosis was the most prevalent cause of this condition, accounting for approximately 70% of cases. In recent times, autoimmune adrenalitis, or Addison disease, has emerged as the leading cause of primary adrenal insufficiency in developed countries. In contrast, tuberculosis remains the leading cause of adrenal insufficiency in developing countries.[10]

Precipitating Factors for Adrenal Crisis

An adrenal crisis most often occurs in a patient with either known primary or secondary adrenal insufficiency. Primary adrenal insufficiency occurs from loss of adrenal gland function and is characterized by low cortisol and high adrenocorticotropic hormone (ACTH). Examples of this include autoimmune destruction of the adrenal gland (Addison disease), surgical removal of the glands, or inborn errors of cortisol production (eg, congenital adrenal hyperplasia). Uncommonly, a patient will have no prior history of autoimmune disease or adrenal insufficiency but will have acquired adrenal insufficiency due to chronic infection, such as from Mycobacterium tuberculosis leading to chronic infectious adrenalitis and fibrosis, or have acute meningococcal meningitis causing Waterhouse-Friderichsen Syndrome and massive bilateral adrenal hemorrhage.[11][12][13][14]

Secondary adrenal insufficiency is most commonly caused by long-term suppression of the pituitary gland production of ACTH by exogenous glucocorticoids, leading to decreased adrenal gland stimulation. This suppression can occur with doses as low as 5 mg of prednisone for 4 weeks or more. Corticosteroid joint injections, steroid creams, and inhaled steroids can also contribute to this. Less commonly, secondary adrenal insufficiency is caused by disruption of the pituitary-adrenal axis by tumors in the pituitary/hypothalamus region. Patients with primary adrenal insufficiency are more likely than secondary causes because aldosterone can also be affected (as can sex hormones).[15]

Acute adrenal crisis can also be the initial presentation of undiagnosed adrenal insufficiency, which occurs in about 50% of patients diagnosed with Addison disease.[16][17][18] In a previous study, approximately 10% of patients exhibited no identifiable cause for their adrenal crisis.[19] The major etiologies of an adrenal crisis are as follows:

  • Gastrointestinal and flu-like illnesses (the most common cause) [3][6][20]
  • Bacterial, mycobacterial, fungal, parasitic, or viral, eg, COVID-19, infections [19][21]
  • Trauma, pregnancy, childbirth, surgery, exposure to extreme hot or cold weather, or other stressful situations
  • Significant emotional distress [19]
  • Strenuous physical activity [22]
  • Nonadherence to glucocorticoid replacement therapy [23]
  • Abrupt cessation of chronic glucocorticoid therapy [23]
  • Thyrotoxicosis (due to acceleration of cortisol metabolism)
  • Levothyroxine therapy initiation in a previously untreated case of adrenal insufficiency [24]
  • Antiadrenal medications, including mitotane, metyrapone, ketoconazole
  • Anticancer medications, including immunotherapy with checkpoint inhibitors and tyrosine kinase inhibitors [25][26][27]

Patients with polyglandular disease (ie, thyroid and adrenal) warrant special attention, as they are at higher risk of adrenal crisis. Patients with hypothyroidism can have masked adrenal insufficiency as they are in a hypometabolic state. When the thyroid hormones are replaced, patients have higher metabolic activity, and hypotension and hypoglycemia due to adrenal insufficiency can occur. Another example is polyglandular autoimmune disease, where patients can have autoimmune destruction of the thyroid, parathyroid, adrenal glands, or pancreas.[24][28] 

Adrenal Crisis Risk Factors

The risk factors associated with adrenal crisis are as follows:

  • A known history of adrenal insufficiency or previous adrenal crisis
  • Primary adrenal insufficiency diagnosis, which carries a higher risk than secondary adrenal insufficiency [16][29]
  • Ongoing glucocorticoid therapy, including topical and inhalation forms, poses a risk for an adrenal crisis due to the potential suppression of the hypothalamic-pituitary-adrenal (HPA) axis if abruptly discontinued
  • Medications, including levothyroxine, phenytoin, phenobarbital, rifampin, carbamazepine, St John's wort, ketoconazole, etomidate, and fluconazole, which affect cortisol metabolism or reduce its production [30][31][32]
  • Anticoagulation agents, which increase the risk of adrenal hemorrhage
  • Additional medications, including megestrol acetate and medroxyprogesterone [33][34][35]
  • Pregnancy, particularly during the third trimester [36]
  • Advanced age [3]
  • The presence of comorbidities [16][29]
  • Patients with type 1 diabetes [3] 
  • Adrenal metastasis or adrenal hemorrhage [37][38]
  • Polyglandular autoimmune syndromes 1 and 2 [39][40]

Epidemiology

Determining the exact frequency of adrenal crises in the general population poses a significant challenge. Patients with adrenal insufficiency have been estimated to experience an adrenal crisis in 6% to 8% of cases annually or 4 to 6 adrenal crises per 100 patient years in those carrying a diagnosis of adrenal insufficiency.[20] The incidence of adrenal crises remains high even among patients who have received extensive education on managing and preventing adrenal insufficiency.[19] A study revealed a 6% mortality rate associated with adrenal crises among this well-informed group of patients.[19] The annual frequency of adrenal crisis in patients with Addison disease remains at 8%.[41]

Pathophysiology

Adrenal Crisis Pathophysiology

The pathophysiology of adrenal crisis is not fully understood; however, examining the functions of glucocorticoids can provide insight into clinical manifestations. Glucocorticoids exhibit various roles in stress responses, demonstrating permissive, suppressive, stimulatory, and preparative effects.[42] For a full discussion of their function, please see StatPearls' companion review, "Physiology of Glucocorticoids."

In general, adrenal or Addisonian crisis refers to an acute status of severe cortisol and/or aldosterone deficiency. The hypothalamus releases corticotropin-releasing hormone (CRH) as a response to an environmental stressor. CRH stimulates the anterior pituitary to release ACTH, which travels through the bloodstream to the adrenal cortex and upregulates cortisol production. Cortisol is a glucocorticoid hormone synthesized from cholesterol by enzymes of the cytochrome P450 family in the zona fasciculate, the middle area of the adrenal cortex.[43]

Cortisol is the primary hormone involved in the human stress response and has multiple effects throughout the body, eg, causing vasoconstriction and inhibiting proinflammatory cytokines. This hormone helps regulate the supply of glucose in the body by triggering gluconeogenesis or stimulating glycogen synthesis in the liver, as well as producing and releasing amino acids from free fatty acids. Cortisol weakens the immune response by preventing T-cell proliferation and preventing T-cells from recognizing interleukin signals.[44] 

Aldosterone deficiency is usually seen in cases of more severe adrenal gland dysfunction involving the whole adrenal gland, eg, Addison disease.[43] Deficient levels of aldosterone cause increased renal sodium loss and potassium reabsorption, resulting in decreased intravascular volume, vascular tone, cardiac output, and renal perfusion. This, in turn, lowers arterial blood pressure, which may lead to postural hypotension, compensatory tachycardia, and eventual vascular collapse. Reduced renal perfusion causes water retention, which dilutes the extracellular fluid and causes the cells to leak potassium, leading to hyperkalemia and metabolic acidosis. Circulatory collapse impairs urinary excretion of waste products, causing elevated blood urea nitrogen and creatinine levels.

Effects of Glucocorticoids on the Cardiovascular System

Glucocorticoids have a permissive effect on the functioning of adrenergic receptors in the heart and vasculature. Without glucocorticoids, catecholamines cannot exert their full impact on these receptors. Consequently, during an adrenal crisis, patients often experience hypotension and, in severe cases, may develop profound shock that remains unresponsive to fluid resuscitation and vasopressor therapy.[45] 

Effects of Glucocorticoids on the Immune System

Infectious or noninfectious stressors can trigger the activation of the immune system, leading to an elevated release of cytokines. Interleukin-1 (IL-1), IL-2, IL-6, tumor necrosis factor (TNF)-α, and TNF-γ have pivotal roles in this immune response. This immune activation subsequently leads to the activation of the HPA axis, resulting in elevated glucocorticoid levels.[46][47] 

Glucocorticoids mitigate immune response by inhibiting cytokine production, release, and effects, thereby playing a crucial role in immune regulation.[48][49] During an adrenal crisis, any significant stressor can trigger an uncontrolled cytokine response, eg, inflammation, resulting in fever, widespread vasodilation, and heightened capillary permeability. This can result in hypovolemia and shock as a consequence of fluid shifting from capillaries into tissues, thereby contributing to the development of hypovolemic shock.

Consequently, during an adrenal crisis, the dysregulation of the immune response, marked by an excessive cytokine release, can result in systemic inflammation, fever, vasodilation, capillary leakage, hypovolemia, and shock.

Effects of Glucocorticoids on the Musculoskeletal System 

Bone health is also affected by glucocorticoid action and is mediated through thyroid hormones. Usually, glucocorticoids inhibit pituitary thyroid-stimulating hormone (TSH) secretion, and with glucocorticoid deficiency, increased TSH causes increased thyroid hormone, which increases bone resorption, causing hypercalcemia. Thyroid hormone is also thought to increase cortisol clearance. The exact mechanisms of hypercalcemia are not known, but several theories exist. Glucocorticoid inhibits activation of 1α-hydroxylation of vitamin D; hence, decreased glucocorticoid may cause increased intestinal calcium absorption. Another proposed theory is that glucocorticoids help preserve osteoblasts. Another possibility is that hypovolemia increases proximal tubular calcium reabsorption. Although hypercalcemia is recognized as a common complication of adrenal insufficiency/adrenal crisis, further studies are needed to delineate the mechanisms by which this occurs.[28][50][51]

Effects of Glucocorticoids on Intravascular Volume

Glucocorticoids can potentially suppress the expression and secretion of antidiuretic hormone (ADH) in the hypothalamic neurons.[52][53] During an adrenal crisis, there is an upsurge in the activity of ADH, leading to increased diuresis and volume depletion.

Effects of Glucocorticoids on the Glucose Homeostasis

Glucocorticoids increase glucose levels in response to stress through various mechanisms, including promoting glycogenolysis and stimulating gluconeogenesis.[54] In addition, glucocorticoids also induce insulin resistance, which reduces glucose uptake by the peripheral cells.[54] During an adrenal crisis, glucocorticoid deficiency hinders these normal stress responses. As a result of the glucocorticoid-deficient state, hypoglycemia can occur due to insufficient glucose production and improved peripheral utilization.

Effects of Glucocorticoids on Appetite Regulation

CRH is a potent appetite suppressant in response to stress.[55] Glucocorticoids are potent inhibitors of CRH release, which can lead to increased appetite.[52] During an adrenal crisis, the release of CRH remains uninhibited in a glucocorticoid-deficient state, leading to anorexia.

Glucocorticoids and Electrolyte Disturbances

Primary adrenal insufficiency causes mineralocorticoid deficiency due to direct destruction of the adrenal cortex. However, the cortex remains intact in secondary and tertiary adrenal insufficiency. The renin-angiotensin-aldosterone system regulates aldosterone production and secretion.[56] An isolated deficiency of ACTH secretion observed in secondary or tertiary adrenal insufficiency does not significantly affect aldosterone levels.[57][56] In primary adrenal insufficiency, aldosterone deficiency is often present, leading to volume loss, hyponatremia, and hyperkalemia.[18] 

Histopathology

The histopathology of adrenal crisis depends on the underlying cause of adrenal insufficiency. Please see StatPearls' companion review, "Adrenal Insufficiency," for further details on histopathological findings.

History and Physical

When evaluating a patient suspected of adrenal crisis, clinicians must thoroughly review the patient's medical history and past surgical history. If the patient is on chronic steroid therapy, compliance with medication is essential, as an adrenal crisis can be precipitated by both the abrupt cessation of steroids or if the patient had an acute stress event and did not increase their steroid dose enough. Additional historical elements that may assist with diagnosis include recent illnesses (eg, gastroenteritis), surgeries, traumatic injuries, or other stressors. Family or a personal history of autoimmune diseases (eg, hypothyroidism or diabetes mellitus) raises the likelihood of other concurrent undiagnosed Addison disease. In addition, clinicians should review the patient's list of home medications and supplements, including inhaled steroids for asthma or COPD, topical steroid creams, and intra-articular injections, as knowing if a patient has a history of adrenal insufficiency or has been on maintenance steroids for any reason is crucial.[58][59]

Identifying any precipitating factors that may trigger an adrenal crisis in individuals is essential. Evaluating other autoimmune diseases in patients while obtaining their history is crucial, as individuals with autoimmune polyglandular endocrinopathy can manifest multiple autoimmune disorders. Furthermore, recurrent hypoglycemia in patients with type 1 diabetes on insulin can indicate adrenal insufficiency. Patients with adrenal crisis usually present with an unexplained shock resistant to standard fluid resuscitation and vasopressor therapy.[60] Given the significant mortality of an adrenal crisis, early recognition and treatment with glucocorticoids and mineralocorticoids (if warranted) is crucial. 

Initial clinical manifestations of adrenal crisis can be nonspecific, including weakness, fatigue, nausea, vomiting, fever, lower chest or abdominal pain, anorexia, back pain, dizziness, somnolence, and confusion. Without appropriate treatment, these symptoms can worsen, quickly developing into hypotension, altered mental status, and obtundation.[3][61] In children, adrenal crises can manifest as weight loss with failure to thrive and are accompanied by other features, including hypoglycemic crises, which may result in seizures. Less frequently observed presentations in individuals of all age groups range from an acute abdomen resembling a surgical emergency to nonspecific symptoms, including salt cravings, amenorrhea, loss of libido, and depression. 

Physical Examination

Assessing a patient's vital signs when evaluating for an adrenal crisis is essential. Patients experiencing an adrenal crisis may exhibit several symptoms, including fever, tachycardia, and orthostatic hypotension.[61] During physical examination, patients may appear visibly unwell. Individuals with primary adrenal insufficiency might display findings including skin and buccal mucosa hyperpigmentation and scarring.[62] Cushingoid signs may also be present, eg, facial fullness, dorsocervical fat pad, truncal obesity with striae, and hirsutism in those who take chronic steroids. Abdominal symptoms may take on features of acute abdomen.[63] Patients may have hyperpyrexia, with temperatures reaching 105 °F (40.5 °C) or higher.[5][20][41] As the patient's cortisol stores are depleted, they will eventually develop circulatory collapse with cyanosis and shock and eventual coma and death if not treated.

Evaluation

Initial laboratory testing should include serum chemistry, complete blood count with differential, cortisol level, ACTH, aldosterone, renin, and thyroid function.[63] In the context of an adrenal crisis, several laboratory abnormalities may be present. However, the classic laboratory findings associated with adrenal crisis include the following:

  • Hyponatremia resulting from mineralocorticoid deficiency
  • Hyperkalemia resulting from mineralocorticoid deficiency
  • Hypoglycemia, stemming from decreased gluconeogenesis and glycogenolysis (more prevalent in children)
  • Low or low normal ACTH levels, as observed in secondary adrenal insufficiency
  • High or high normal ACTH levels, as observed in primary adrenal insufficiency
  • Hypercalcemia, resulting from hypovolemia, increased 1,25 Vitamin D, or bone metabolism alterations (Please refer to the Pathophysiology section for more information)
  • Elevated creatinine levels, attributed to prerenal failure
  • High renin levels, as typically seen in primary adrenal insufficiency due to increased urinary sodium loss and reduced blood volume
  • Normocytic normochromic anemia, lymphocytosis, and eosinophilia, resulting from glucocorticoid deficiency
  • Increased TSH levels [15]

An acutely stressful event such as sepsis typically stimulates cortisol production, which decreases eosinophil counts. However, patients with adrenal insufficiency cannot increase their cortisol reserves. Thus, normal or increased eosinophil counts in an unstable patient raise the possibility of an adrenal etiology. Increased TSH levels can occur due to coexisting hypothyroidism in autoimmune polyglandular endocrinopathy or the absence of cortisol's inhibitory effect on TSH production. Per the Society for Endocrine Emergency Guidelines, thyroid hormone should not be replaced unless the TSH level is >10 mU/L.[15]

The treatment of adrenal crises should never be delayed to obtain blood work to determine the underlying etiology. Prompt administration of hydrocortisone is of the utmost importance in managing adrenal crises. However, if no delay in treatment is anticipated, blood work can be performed quickly before initiating hydrocortisone administration. In situations with diagnostic uncertainty and borderline cortisol levels, performing an ACTH stimulation test in the acute setting is not recommended until the patient's condition has stabilized.[64]

Additional Diagnostic Studies 

An electrocardiogram (ECG) may show peaked T waves from hyperkalemia or short QT interval from hypercalcemia. A chest radiograph, urine studies, and blood cultures should be ordered to evaluate for any infection. A computed tomography (CT) scan of the abdomen may show hemorrhage in the adrenals, calcification of the adrenals as seen with tuberculosis, or metastasis. In cases of secondary adrenal insufficiency, a head CT scan may show the destruction of the pituitary (ie, empty sella syndrome) or a pituitary mass lesion.[65]

Treatment / Management

An adrenal crisis requires prompt identification and treatment. This medical emergency necessitates maximal supportive care and monitoring in the intensive care unit. The administration of glucocorticoids, specifically hydrocortisone, constitutes the definitive treatment for adrenal crisis. In patients with known adrenal insufficiency, symptoms consistent with an adrenal crisis should be sufficient to initiate treatment. If a patient is medically unstable and is strongly suspected of adrenal insufficiency or crisis, stress dose steroids should be administered promptly.[66] The administrative dosing of stress dose steroids and fluid resuscitation differs in children from adults (see Table. Emergent Adrenal Crisis Management Guidelines). 

Table. Emergent Adrenal Crisis Management Guidelines

(A1)
 Age Groups Stress Dosing Fluid Resuscitation
Adults

The recommended treatment regimen includes administering an initial dose of 100 mg of hydrocortisone through intravenous or intramuscular (IV/IM) bolus injection. This is followed by administering an additional 200 mg of hydrocortisone as IM or IV over the next 24 hours, with a dosage of 50 mg every 6 hours or as a continuous infusion.[3]

The suggested treatment approach for hypovolemia is administering either 1 L of normal saline or 5% dextrose in 1 L of normal saline, followed by maintenance fluids.[3]

Children

Hydrocortisone dosage is initially calculated as 50 to 100 mg/m² of body surface area, followed by an additional 50 to 100 mg/m² over the next 24 hours, administered as IM/IV, divided into equal doses every 6 hours, or as a continuous infusion.[31][67]

The suggested treatment regimen is administering a normal saline bolus at 20 mL/kg of body weight, with repeated doses up to 60 mL/kg within the first hour. If hypoglycemia is present, additional dextrose should be considered at a dose of 0.5 to 1 g/kg.[31]

In cases of adrenal crisis, involving an endocrinologist as soon as possible is crucial to ensure appropriate management of the condition and guidance in patient care. Recent evidence indicates that continuous infusion is a superior delivery method for hydrocortisone in the management of adrenal crises when compared to intermittent boluses.[68] Continuous hydrocortisone infusion has shown better maintenance of cortisol levels within the therapeutic range. Once there is clinical improvement, initiating a gradual tapering of steroids is advisable.[69] This approach helps prevent abrupt discontinuation and enables a smoother transition to lower doses. 

The necessity for mineralocorticoid replacement should be assessed individually and in consultation with an endocrinologist. Mineralocorticoid replacement is unnecessary if the glucocorticoid doses administered to patients exceed 50 mg.[70] In situations where hydrocortisone is unavailable, the following alternative parenteral glucocorticoids can be considered:[3][31](A1)

  • Prednisolone: A preferred alternative treatment, prednisolone is administered as an initial bolus of 25 mg, followed by 2 additional 25 mg doses within the first 24 hours. Subsequently, this regimen should be continued with a daily dose of 50 mg of prednisone.
  • Methylprednisolone: This can be administered at a dosage of 40 mg every 24 hours.
  • Dexamethasone: This alternative is the least preferred, with a recommended dosage of 4 mg every 24 hours.

In patients with an infectious process as the precipitating event for adrenal crisis, prompt administration of appropriate antibiotics is necessary to address the underlying infection. 

Differential Diagnosis

An adrenal crisis is rarely an isolated event and has a wide array of differential diagnoses, depending on the presentation and underlying etiology. Although symptoms such as altered mental status, abdominal pain, nausea, vomiting, and fever are frequently encountered during presentations, hypotension typically remains the most significant feature. An adrenal crisis should be considered the primary differential diagnosis for patients with a known history of adrenal insufficiency and experiencing related symptoms.[71] 

Further investigation is necessary to determine the underlying cause of the adrenal crisis and potential secondary triggers. In patients without a known adrenal pathology and exhibiting hypotension resistant to fluid administration and vasopressor support, the diagnosis of adrenal crisis should be strongly considered.[5] Differential diagnoses that should also be considered include: 

  • Shock
    • Cardiogenic
    • Obstructive
    • Distributive
    • Hypovolemic
    • Septic
  • Cardiac
    • Acute myocardial infarction
  • Endocrine
    • Thyrotoxicosis
    • Diabetic ketoacidosis
    • Hyperosmolar hyperglycemic state
    • Myxedema coma
    • Pituitary adenoma
  • Gastrointestinal
    • Dehydration
    • Gastroenteritis
    • Poor oral intake
    • Acute abdomen (eg, appendicitis, diverticulitis, obstruction)
  • Hematology and oncology
    • History of melanoma, breast cancers, or immunotherapy with a checkpoint inhibitor
    • Malignancy
  • Obstetrics
    • Pregnancy
    • Hyperemesis gravidarum
  • Infectious
    • Acute localized or systemic infection
  • Stressors
    • Trauma 
    • Recent surgery
    • Psychological stress

Prognosis

Despite the potential for successful treatment with prompt administration of glucocorticoids, the associated mortality rate remains unacceptably high for adrenal crisis. Due to its rarity, many healthcare professionals may have limited familiarity with the presentation and management of adrenal crises. A retrospective study in the United Kingdom revealed that adrenal crisis contributed to 10% of the deaths in patients with primary and secondary adrenal insufficiency.[72] 

Patients whose adrenal crisis is quickly identified and given prompt treatment with IV fluids and parenteral steroids have a good prognosis and recovery. Those who are critically ill with significantly altered mental status, advanced endocrinopathies (eg, severe diabetes and uncontrolled thyroid disease), or multiple comorbidities have an increased risk of mortality and residual disability. The patient may need physical or occupational therapy and rehabilitation to regain independent function. 

Complications

An adrenal crisis can result in fatal outcomes, even with timely recognition and appropriate treatment.[2] Besides the risk of death, adrenal crisis is associated with other potential complications. Electrolyte abnormalities, such as hyponatremia, hyperkalemia, and hypoglycemia, can lead to various complications, including seizures, arrhythmias, and coma.[71] If left untreated, hypotension can lead to hypoperfusion, potentially resulting in multiple organ failure. Furthermore, the precipitating disease or event that triggered the adrenal crisis can introduce additional complications.[62]

Despite receiving steroid replacement therapy, individuals who have experienced adrenal crises often face significant challenges in their quality of life. Studies have indicated that many individuals suffer from disabilities and are unable to work due to conditions such as depression and chronic fatigue, thereby leading to a poor quality of life.[73] 

Adrenal crises continue to maintain an unacceptably high mortality rate. Although the exact cause of mortality may not be apparent in all cases, experts believe it to be attributed to respiratory infections, adverse cardiovascular events, and stroke.[1] Despite extensive efforts in patient education, the incidence of adrenal crisis–related mortality remains significant. A study involving 423 participants reported an adrenal crisis–related mortality rate as high as 6%.[19] In a previous study, patient satisfaction with managing adrenal crises in the emergency setting was as low as 66%.[74]

Consultations

Consultations that may be required in the management of an adrenal crisis include:

  • Critical care: For intensive care management and close monitoring due to the high risk of decompensation
  • Endocrinology: To manage long-term steroid therapy and address underlying adrenal insufficiency
  • Cardiology: If cardiac involvement or hemodynamic instability is suspected
  • Gastroenterology: For gastrointestinal issues contributing to or resulting from the crisis
  • Infectious disease: If an infection is identified or suspected as the precipitating factor
  • Other specialists: Based on specific clinical findings or complications (eg, nephrology for renal issues)

Deterrence and Patient Education

More than 50% of patients with adrenal crisis do not have a prior diagnosis of adrenal insufficiency. Therefore, clinician familiarity with the diagnosis and use of stress dose steroids to manage adrenal crises effectively is essential.[71] Additionally, patients should be educated by their clinicians based on the following guidelines:

  • Patients should be aware of the sick day rules, which involve doubling or tripling their daily oral dose of glucocorticoids during an acute illness. This helps mimic the physiological response of increased cortisol levels under stressful situations.[23]
    • For a fever exceeding 100.4 °F (38 °C), doubling the oral corticosteroid dose is recommended.
    • For a fever exceeding 102.2 °F (39 °C), tripling the oral corticosteroid dose is recommended.
  • Patients should know how to administer stress doses during stressful situations, including trauma, surgery, major procedures, and severe illness (see Table. Strategies for Adrenal Crisis Prevention). In cases of significant emotional stress, eg, the death of a loved one or the anticipation of a significant upcoming examination, patients are recommended to take an additional dose of 10 mg of hydrocortisone to help manage the situation.[23]
  • Patients should be educated about the signs and symptoms of adrenal insufficiency to facilitate early recognition and management. Some common signs and symptoms include nausea, vomiting, abdominal pain, unintentional weight loss, dizziness, confusion, low blood glucose, fever, and a diminished sense of well-being.
  • Patients with adrenal insufficiency should be informed that wearing a medical alert bracelet or necklace is paramount for managing this condition. This simple yet crucial accessory can provide essential information to clinicians during emergencies, ensuring the prompt delivery of utmost and appropriate care.[31][69]
  • Patients should also ensure they have additional emergency supplies at home, which should be readily available and can be utilized as and when required.[15] An emergency kit should include injectable vials of 100 mg hydrocortisone sodium succinate or 4 mg dexamethasone, 0.9% sterile normal saline vials, and syringes.
  • Patients should have a steroid card that provides information and instructions for managing an adrenal crisis. This card should be easily accessible and readily available, especially in emergencies or when seeking medical care at a hospital or healthcare facility. Maintaining this card is crucial for patients as healthcare professionals at these facilities may not be familiar with managing adrenal crises. The steroid card should clearly outline the recommended dosing information for glucocorticoid administration during an adrenal crisis. The recommended dosage is 100 mg of hydrocortisone administered IV or IM, followed by an additional 200 mg of hydrocortisone over the next 24 hours. This should also be administered IM or IV in equally divided doses of 50 mg every 6 hours.
  • Patients should regularly schedule follow-up appointments with an endocrinologist, which is essential for monitoring their condition, optimizing treatment, and discussing stress dosing as needed. The recommended frequency of follow-up is annually for adults and every 3 to 6 months for children.

Table. Strategies for Adrenal Crisis Prevention

Stressors  Dosage Adjustments
Infection with fever >38 °C [3][23] Patients should double their oral corticosteroid dose until recovery and then gradually decrease it to the baseline dose in 2 days.
Infection with fever >39 °C [3][23] Patients should triple their oral corticosteroid dose until recovery and then gradually decrease it to the baseline dose in 2 days.
Severe infections requiring admission to the intensive care unit (ICU) [3] Patients should receive parenteral IV/IM or subcutaneous (SQ) hydrocortisone administered at 50 to 100 mg every 6 to 12 hours until recovery.
Major surgery [75] Patients should receive parental (IV/IM/SQ) hydrocortisone administered at a dose of 100 mg during the induction of anesthesia, followed by 50 to 100 mg every 6 to 12 hours until recovery.
Minor surgery or major dental surgery [75]

Patients should administer 100 mg of hydrocortisone during the induction of anesthesia, followed by a double oral dose for 24 hours, and then gradually return to the baseline dose.

 

During labor [75]

Patients should administer 100 mg of hydrocortisone at the onset of labor, followed by an additional 25 to 50 mg every 6 hours, and then gradually reduce the dose over the next 3 days.

Significant emotional stress, such as the death of a loved one or the anticipation of a significant upcoming examination [23]

Patients should administer an additional 10 to 20 mg of hydrocortisone to their baseline dose.

 

Prolonged intensive strenuous exercise [23]

Patients should administer an additional 10 mg of hydrocortisone 30 to 60 minutes before exercise.

Dental procedure Patients should take an additional dose of hydrocortisone 1 hour before the procedure, followed by a double dose for the next 24 hours. Subsequently, they can return to their regular dosage.
Minor procedure No dosage adjustment is needed.

Pearls and Other Issues

Key factors that should be kept in mind in the management of adrenal crisis:

  • An adrenal crisis should be suspected in patients who exhibit acute refractory shock despite receiving adequate fluid resuscitation and vasopressor support. Adrenal crises may be more frequently observed in older patients and individuals with comorbidities and concurrent endocrine disorders. Patients experiencing altered mental status in conjunction with endocrine disorders may face an increased mortality risk.
  • Hyponatremia, hyperkalemia, or hypoglycemia, especially with hypotension, may indicate an adrenal crisis. In suspected adrenal crises, immediate administration of 100 mg hydrocortisone via IV or IM route is crucial. Prompt initiation of glucocorticoid therapy is also essential for managing adrenal crises and preventing further deterioration.
  • Overall, an adrenal crisis is a life-threatening emergency requiring clinicians to recognize the underlying adrenal insufficiency and to treat with IV fluid resuscitation and IV hydrocortisone promptly while simultaneously working up the etiology that triggered the acute decompensation. 
  • In the setting of shock, adrenal insufficiency often is low on the list of differentials. An important clue to diagnosis is hypotension resistant to vasopressor and IV fluid support. 
  • The most common triggering event is gastrointestinal infection. However, any other condition that causes stress on the body can lead to an acute crisis. 
  • Adrenal crisis can occur both in those previously undiagnosed or those diagnosed with adrenal insufficiency.
  • Primary adrenal insufficiency is characterized by low cortisol and high ACTH from the destruction of the adrenal glands. Aldosterone deficiency is also a critical feature of primary adrenal insufficiency, this is characterized by hyponatremia and hyperkalemia.
  • Secondary adrenal insufficiency is characterized by low cortisol and low to normal ACTH caused by decreased ACTH secretion from the pituitary.
  • An ACTH stimulation test can be performed to diagnose adrenal insufficiency. Those with concurrent endocrinopathies or autoimmune disease or who have a family history of such diseases are at high risk for adrenal insufficiency. When an adrenal crisis is suspected, lab testing results should not delay immediate treatment with hydrocortisone or an equivalent.
  • Patients and their families will need to be educated on strategies to prevent acute decompensation and how any triggering event will require an adjustment of their steroid doses.
  • A team-based approach between clinicians and the patient is essential in maintaining control of this condition. 

Enhancing Healthcare Team Outcomes

Effective management of adrenal crises, especially in intensive care settings, demands a coordinated interprofessional approach due to the condition's complexity and high mortality risk. This team typically includes intensivists, endocrinologists, critical care nurses, pharmacists, and other healthcare professionals. Critical care nurses are pivotal in monitoring vital signs, urine output, and hemodynamic status, ensuring early recognition of deterioration and timely interventions. They also collaborate with the multidisciplinary team to educate patients and families on the condition, its complications, and the importance of adherence to sick day rules and medication adjustments. Avoiding abrupt cessation of corticosteroids, a common trigger, is a key educational point emphasized by clinicians and pharmacists, who also counsel on the adverse effects of these medications. Patients are encouraged to wear medical alert identification to facilitate emergency care.

Strategic and evidence-based approaches guide treatment plans, emphasizing ethical principles such as informed consent and respect for patient autonomy. Each team member brings unique expertise, ensuring a comprehensive care plan that addresses all aspects of the patient's needs. Effective interprofessional communication enables seamless exchange of information and collaborative decision-making, while robust care coordination ensures continuity from diagnosis to follow-up, minimizing errors and enhancing safety. By integrating skills, strategic planning, ethical responsibility, interprofessional collaboration, and meticulous care coordination, healthcare professionals provide patient-centered care, improving outcomes, safety, and overall team performance in managing adrenal crises.

References


[1]

Rushworth RL, Torpy DJ, Stratakis CA, Falhammar H. Adrenal Crises in Children: Perspectives and Research Directions. Hormone research in paediatrics. 2018:89(5):341-351. doi: 10.1159/000481660. Epub 2018 Jun 6     [PubMed PMID: 29874655]

Level 3 (low-level) evidence

[2]

Hahner S. Acute adrenal crisis and mortality in adrenal insufficiency: Still a concern in 2018! Annales d'endocrinologie. 2018 Jun:79(3):164-166. doi: 10.1016/j.ando.2018.04.015. Epub 2018 Apr 30     [PubMed PMID: 29716733]


[3]

Rushworth RL, Torpy DJ, Falhammar H. Adrenal Crisis. The New England journal of medicine. 2019 Aug 29:381(9):852-861. doi: 10.1056/NEJMra1807486. Epub     [PubMed PMID: 31461595]


[4]

Higham CE, Olsson-Brown A, Carroll P, Cooksley T, Larkin J, Lorigan P, Morganstein D, Trainer PJ, Society for Endocrinology Clinical Committee. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy. Endocrine connections. 2018 Jul:7(7):G1-G7. doi: 10.1530/EC-18-0068. Epub     [PubMed PMID: 29930025]


[5]

Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR. Adrenal Crisis: Still a Deadly Event in the 21st Century. The American journal of medicine. 2016 Mar:129(3):339.e1-9. doi: 10.1016/j.amjmed.2015.08.021. Epub 2015 Sep 9     [PubMed PMID: 26363354]


[6]

Alexandraki KI, Grossman A. Management of Hypopituitarism. Journal of clinical medicine. 2019 Dec 5:8(12):. doi: 10.3390/jcm8122153. Epub 2019 Dec 5     [PubMed PMID: 31817511]


[7]

Upadhyay J, Sudhindra P, Abraham G, Trivedi N. Tuberculosis of the adrenal gland: a case report and review of the literature of infections of the adrenal gland. International journal of endocrinology. 2014:2014():876037. doi: 10.1155/2014/876037. Epub 2014 Aug 6     [PubMed PMID: 25165474]

Level 3 (low-level) evidence

[8]

Burns CM. The History of Cortisone Discovery and Development. Rheumatic diseases clinics of North America. 2016 Feb:42(1):1-14, vii. doi: 10.1016/j.rdc.2015.08.001. Epub     [PubMed PMID: 26611547]


[9]

Gidlöf S, Falhammar H, Thilén A, von Döbeln U, Ritzén M, Wedell A, Nordenström A. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. The lancet. Diabetes & endocrinology. 2013 Sep:1(1):35-42. doi: 10.1016/S2213-8587(13)70007-X. Epub 2013 Feb 26     [PubMed PMID: 24622265]

Level 2 (mid-level) evidence

[10]

Omori K, Nomura K, Shimizu S, Omori N, Takano K. Risk factors for adrenal crisis in patients with adrenal insufficiency. Endocrine journal. 2003 Dec:50(6):745-52     [PubMed PMID: 14709847]

Level 2 (mid-level) evidence

[11]

Koo DJ, Jackman D, Chaudry IH, Wang P. Adrenal insufficiency during the late stage of polymicrobial sepsis. Critical care medicine. 2001 Mar:29(3):618-22     [PubMed PMID: 11373430]

Level 3 (low-level) evidence

[12]

Santos AR, Bello CT, Sousa A, Duarte JS, Campos L. Pituitary Apoplexy Following Systemic Anticoagulation. European journal of case reports in internal medicine. 2019:6(12):001254. doi: 10.12890/2019_001254. Epub 2019 Nov 1     [PubMed PMID: 31893198]

Level 3 (low-level) evidence

[13]

Bornstein SR. Predisposing factors for adrenal insufficiency. The New England journal of medicine. 2009 May 28:360(22):2328-39. doi: 10.1056/NEJMra0804635. Epub     [PubMed PMID: 19474430]


[14]

Vinnard C, Blumberg EA. Endocrine and Metabolic Aspects of Tuberculosis. Microbiology spectrum. 2017 Jan:5(1):. doi: 10.1128/microbiolspec.TNMI7-0035-2016doi: 10.1128/microbiolspec.tnmi7-0035-2016. Epub     [PubMed PMID: 28233510]


[15]

Arlt W, Society for Endocrinology Clinical Committee. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocrine connections. 2016 Sep:5(5):G1-G3     [PubMed PMID: 27935813]


[16]

Smans LC, Van der Valk ES, Hermus AR, Zelissen PM. Incidence of adrenal crisis in patients with adrenal insufficiency. Clinical endocrinology. 2016 Jan:84(1):17-22. doi: 10.1111/cen.12865. Epub 2015 Aug 27     [PubMed PMID: 26208266]


[17]

Bleicken B, Hahner S, Ventz M, Quinkler M. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. The American journal of the medical sciences. 2010 Jun:339(6):525-31. doi: 10.1097/MAJ.0b013e3181db6b7a. Epub     [PubMed PMID: 20400889]

Level 2 (mid-level) evidence

[18]

Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. The Journal of clinical endocrinology and metabolism. 2009 Dec:94(12):4882-90. doi: 10.1210/jc.2009-1368. Epub 2009 Oct 26     [PubMed PMID: 19858318]


[19]

Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, Beuschlein F, Willenberg HS, Quinkler M, Allolio B. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. The Journal of clinical endocrinology and metabolism. 2015 Feb:100(2):407-16. doi: 10.1210/jc.2014-3191. Epub 2014 Nov 24     [PubMed PMID: 25419882]


[20]

Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, Ventz M, Quinkler M, Allolio B. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. European journal of endocrinology. 2010 Mar:162(3):597-602. doi: 10.1530/EJE-09-0884. Epub 2009 Dec 2     [PubMed PMID: 19955259]

Level 2 (mid-level) evidence

[21]

Heidarpour M, Vakhshoori M, Abbasi S, Shafie D, Rezaei N. Adrenal insufficiency in coronavirus disease 2019: a case report. Journal of medical case reports. 2020 Aug 24:14(1):134. doi: 10.1186/s13256-020-02461-2. Epub 2020 Aug 24     [PubMed PMID: 32838801]

Level 3 (low-level) evidence

[22]

Lousada LM, Mendonca BB, Bachega TASS. Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia. Archives of endocrinology and metabolism. 2021 Nov 3:65(4):488-494. doi: 10.20945/2359-3997000000392. Epub 2021 Jul 16     [PubMed PMID: 34283908]


[23]

Allolio B. Extensive expertise in endocrinology. Adrenal crisis. European journal of endocrinology. 2015 Mar:172(3):R115-24. doi: 10.1530/EJE-14-0824. Epub 2014 Oct 6     [PubMed PMID: 25288693]


[24]

Hoener K, Sharma T. Type II polyglandular autoimmune syndrome: a case of Addison's disease precipitated by use of levothyroxine. BMJ case reports. 2019 Aug 21:12(8):. doi: 10.1136/bcr-2019-230760. Epub 2019 Aug 21     [PubMed PMID: 31439557]

Level 3 (low-level) evidence

[25]

Joshi MN, Whitelaw BC, Palomar MT, Wu Y, Carroll PV. Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clinical endocrinology. 2016 Sep:85(3):331-9. doi: 10.1111/cen.13063. Epub 2016 Apr 13     [PubMed PMID: 26998595]


[26]

Elshimy G, Gandhi A, Guo R, Correa R. Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer. Journal of investigative medicine high impact case reports. 2020 Jan-Dec:8():2324709620936808. doi: 10.1177/2324709620936808. Epub     [PubMed PMID: 32583692]

Level 3 (low-level) evidence

[27]

Lodish MB. Clinical review: kinase inhibitors: adverse effects related to the endocrine system. The Journal of clinical endocrinology and metabolism. 2013 Apr:98(4):1333-42. doi: 10.1210/jc.2012-4085. Epub 2013 Feb 28     [PubMed PMID: 23450053]


[28]

Choo KS, Yew J, Tan EJH, Puar THK. Case Report: Hypercalcemia as a manifestation of acute adrenal crisis precipitated by fluconazole use, and a review of the literature. Frontiers in endocrinology. 2023:14():1168797. doi: 10.3389/fendo.2023.1168797. Epub 2023 May 18     [PubMed PMID: 37274338]

Level 3 (low-level) evidence

[29]

Iwasaku M, Shinzawa M, Tanaka S, Kimachi K, Kawakami K. Clinical characteristics of adrenal crisis in adult population with and without predisposing chronic adrenal insufficiency: a retrospective cohort study. BMC endocrine disorders. 2017 Sep 11:17(1):58. doi: 10.1186/s12902-017-0208-0. Epub 2017 Sep 11     [PubMed PMID: 28893233]

Level 2 (mid-level) evidence

[30]

Arlt W, Allolio B. Adrenal insufficiency. Lancet (London, England). 2003 May 31:361(9372):1881-93     [PubMed PMID: 12788587]


[31]

Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2016 Feb:101(2):364-89. doi: 10.1210/jc.2015-1710. Epub 2016 Jan 13     [PubMed PMID: 26760044]

Level 1 (high-level) evidence

[32]

Shibata S, Kami M, Kanda Y, Machida U, Iwata H, Kishi Y, Takeshita A, Miyakoshi S, Ueyama J, Morinaga S, Mutou Y. Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide. American journal of hematology. 2001 Apr:66(4):303-5     [PubMed PMID: 11279645]

Level 3 (low-level) evidence

[33]

Orme LM, Bond JD, Humphrey MS, Zacharin MR, Downie PA, Jamsen KM, Mitchell SL, Robinson JM, Grapsas NA, Ashley DM. Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression. Cancer. 2003 Jul 15:98(2):397-405     [PubMed PMID: 12872362]

Level 2 (mid-level) evidence

[34]

Naing KK, Dewar JA, Leese GP. Megestrol acetate therapy and secondary adrenal suppression. Cancer. 1999 Sep 15:86(6):1044-9     [PubMed PMID: 10491532]


[35]

Hellman L, Yoshida K, Zumoff B, Levin J, Kream J, Fukushima DK. The effect of medroxyprogesterone acetate on the pituitary-adrenal axis. The Journal of clinical endocrinology and metabolism. 1976 May:42(5):912-7     [PubMed PMID: 178684]


[36]

Yuen KC, Chong LE, Koch CA. Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management. Endocrine. 2013 Oct:44(2):283-92. doi: 10.1007/s12020-013-9893-2. Epub 2013 Feb 2     [PubMed PMID: 23377701]


[37]

Tallis PH, Rushworth RL, Torpy DJ, Falhammar H. Adrenal insufficiency due to bilateral adrenal metastases - A systematic review and meta-analysis. Heliyon. 2019 May:5(5):e01783. doi: 10.1016/j.heliyon.2019.e01783. Epub 2019 May 29     [PubMed PMID: 31193734]

Level 1 (high-level) evidence

[38]

Ramon I, Mathian A, Bachelot A, Hervier B, Haroche J, Boutin-Le Thi Huong D, Costedoat-Chalumeau N, Wechsler B, Karmali R, Velkeniers B, Touraine P, Coussieu C, Bennani A, Renard-Penna R, Grenier PA, Wahl D, Piette JC, Amoura Z. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients. The Journal of clinical endocrinology and metabolism. 2013 Aug:98(8):3179-89. doi: 10.1210/jc.2012-4300. Epub 2013 Jun 19     [PubMed PMID: 23783099]

Level 2 (mid-level) evidence

[39]

Bain A, Stewart M, Mwamure P, Nirmalaraj K. Addison's disease in a patient with hypothyroidism: autoimmune polyglandular syndrome type 2. BMJ case reports. 2015 Aug 3:2015():. doi: 10.1136/bcr-2015-210506. Epub 2015 Aug 3     [PubMed PMID: 26240101]

Level 3 (low-level) evidence

[40]

Puttanna A, Cunningham AR, Dainty P. Addison's disease and its associations. BMJ case reports. 2013 Jul 26:2013():. doi: 10.1136/bcr-2013-010473. Epub 2013 Jul 26     [PubMed PMID: 23893277]

Level 3 (low-level) evidence

[41]

White K, Arlt W. Adrenal crisis in treated Addison's disease: a predictable but under-managed event. European journal of endocrinology. 2010 Jan:162(1):115-20. doi: 10.1530/EJE-09-0559. Epub 2009 Sep 23     [PubMed PMID: 19776201]


[42]

Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine reviews. 2000 Feb:21(1):55-89     [PubMed PMID: 10696570]

Level 3 (low-level) evidence

[43]

Gupta P, Bhatia V. Corticosteroid physiology and principles of therapy. Indian journal of pediatrics. 2008 Oct:75(10):1039-44. doi: 10.1007/s12098-008-0208-1. Epub 2008 Nov 21     [PubMed PMID: 19023528]


[44]

Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, Lowry SF. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. Journal of immunology (Baltimore, Md. : 1950). 1993 Mar 1:150(5):1999-2006     [PubMed PMID: 8436830]


[45]

Malbon CC, Rapiejko PJ, Watkins DC. Permissive hormone regulation of hormone-sensitive effector systems. Trends in pharmacological sciences. 1988 Jan:9(1):33-6     [PubMed PMID: 3072728]


[46]

Turnbull AV, Rivier C. Regulation of the HPA axis by cytokines. Brain, behavior, and immunity. 1995 Dec:9(4):253-75     [PubMed PMID: 8903845]

Level 3 (low-level) evidence

[47]

Bellavance MA, Rivest S. The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain. Frontiers in immunology. 2014:5():136. doi: 10.3389/fimmu.2014.00136. Epub 2014 Mar 31     [PubMed PMID: 24744759]


[48]

Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C, Miller AH. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology. 1999 Sep:140(9):4359-66     [PubMed PMID: 10465310]

Level 3 (low-level) evidence

[49]

Quatrini L, Ugolini S. New insights into the cell- and tissue-specificity of glucocorticoid actions. Cellular & molecular immunology. 2021 Feb:18(2):269-278. doi: 10.1038/s41423-020-00526-2. Epub 2020 Aug 31     [PubMed PMID: 32868909]


[50]

Magacha HM, Parvez MA, Vedantam V, Makahleh L, Vedantam N. Unexplained Hypercalcemia: A Clue to Adrenal Insufficiency. Cureus. 2023 Jul:15(7):e42405. doi: 10.7759/cureus.42405. Epub 2023 Jul 24     [PubMed PMID: 37637567]


[51]

Yamada S, Arase H, Morishita T, Tsuchimoto A, Torisu K, Torisu T, Tsuruya K, Nakano T, Kitazono T. Adrenal crisis presented as acute onset of hypercalcemia and hyponatremia triggered by acute pyelonephritis in a patient with partial hypopituitarism and pre-dialysis chronic kidney disease. CEN case reports. 2019 May:8(2):83-88. doi: 10.1007/s13730-018-0371-9. Epub 2018 Nov 19     [PubMed PMID: 30456557]

Level 3 (low-level) evidence

[52]

Erkut ZA, Pool C, Swaab DF. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. The Journal of clinical endocrinology and metabolism. 1998 Jun:83(6):2066-73     [PubMed PMID: 9626140]


[53]

Kim JK, Summer SN, Wood WM, Schrier RW. Role of glucocorticoid hormones in arginine vasopressin gene regulation. Biochemical and biophysical research communications. 2001 Dec 21:289(5):1252-6     [PubMed PMID: 11741329]

Level 3 (low-level) evidence

[54]

Kuo T, McQueen A, Chen TC, Wang JC. Regulation of Glucose Homeostasis by Glucocorticoids. Advances in experimental medicine and biology. 2015:872():99-126. doi: 10.1007/978-1-4939-2895-8_5. Epub     [PubMed PMID: 26215992]

Level 3 (low-level) evidence

[55]

Sominsky L, Spencer SJ. Eating behavior and stress: a pathway to obesity. Frontiers in psychology. 2014:5():434. doi: 10.3389/fpsyg.2014.00434. Epub 2014 May 13     [PubMed PMID: 24860541]


[56]

Bollag WB. Regulation of aldosterone synthesis and secretion. Comprehensive Physiology. 2014 Jul:4(3):1017-55. doi: 10.1002/cphy.c130037. Epub     [PubMed PMID: 24944029]

Level 3 (low-level) evidence

[57]

Esposito D, Pasquali D, Johannsson G. Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy. The Journal of clinical endocrinology and metabolism. 2018 Feb 1:103(2):376-387. doi: 10.1210/jc.2017-01928. Epub     [PubMed PMID: 29156052]


[58]

Robati S, Shahid MK, Vella A, Rang S. Importance of a thorough drug history in presurgical patients. BMJ case reports. 2014 Mar 14:2014():. doi: 10.1136/bcr-2013-202667. Epub 2014 Mar 14     [PubMed PMID: 24632903]

Level 3 (low-level) evidence

[59]

Hayes B, Mahady S, McGuire A, Sforza A, Sforza J, Piedimonte G, Skoner DP. Dangers of under-treatment and over-treatment with inhaled corticosteroids in children with asthma. Pediatric pulmonology. 2025 Jan:60(1):e27327. doi: 10.1002/ppul.27327. Epub 2024 Nov 8     [PubMed PMID: 39513639]


[60]

Hopkins RL, Leinung MC. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinology and metabolism clinics of North America. 2005 Jun:34(2):371-84, ix     [PubMed PMID: 15850848]


[61]

Claessen KMJA, Andela CD, Biermasz NR, Pereira AM. Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective. Frontiers in endocrinology. 2021:12():701365. doi: 10.3389/fendo.2021.701365. Epub 2021 Jul 20     [PubMed PMID: 34354671]

Level 3 (low-level) evidence

[62]

Dineen R, Thompson CJ, Sherlock M. Adrenal crisis: prevention and management in adult patients. Therapeutic advances in endocrinology and metabolism. 2019:10():2042018819848218. doi: 10.1177/2042018819848218. Epub 2019 Jun 13     [PubMed PMID: 31223468]

Level 3 (low-level) evidence

[63]

Bouillon R. Acute adrenal insufficiency. Endocrinology and metabolism clinics of North America. 2006 Dec:35(4):767-75, ix     [PubMed PMID: 17127145]


[64]

Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN, Maghnie M, Rose SR, Soule SG, Tordjman K, Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. The Journal of clinical endocrinology and metabolism. 2008 Nov:93(11):4245-53. doi: 10.1210/jc.2008-0710. Epub 2008 Aug 12     [PubMed PMID: 18697868]

Level 1 (high-level) evidence

[65]

Sherlock M, Gittoes NJ, Arlt W. Adrenal crisis causing critical illness related reversible myocardial dysfunction. Clinical endocrinology. 2008 Apr:68(4):667-9     [PubMed PMID: 17941905]

Level 3 (low-level) evidence

[66]

Oelkers W. Adrenal insufficiency. The New England journal of medicine. 1996 Oct 17:335(16):1206-12     [PubMed PMID: 8815944]


[67]

Malikova J, Flück CE. Novel insight into etiology, diagnosis and management of primary adrenal insufficiency. Hormone research in paediatrics. 2014:82(3):145-57. doi: 10.1159/000363107. Epub 2014 Aug 1     [PubMed PMID: 25096886]


[68]

Prete A, Taylor AE, Bancos I, Smith DJ, Foster MA, Kohler S, Fazal-Sanderson V, Komninos J, O'Neil DM, Vassiliadi DA, Mowatt CJ, Mihai R, Fallowfield JL, Annane D, Lord JM, Keevil BG, Wass JAH, Karavitaki N, Arlt W. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery. The Journal of clinical endocrinology and metabolism. 2020 Jul 1:105(7):2262-74. doi: 10.1210/clinem/dgaa133. Epub     [PubMed PMID: 32170323]


[69]

Guignat L. Therapeutic patient education in adrenal insufficiency. Annales d'endocrinologie. 2018 Jun:79(3):167-173. doi: 10.1016/j.ando.2018.03.002. Epub 2018 Mar 29     [PubMed PMID: 29606279]


[70]

Shenker Y, Skatrud JB. Adrenal insufficiency in critically ill patients. American journal of respiratory and critical care medicine. 2001 Jun:163(7):1520-3     [PubMed PMID: 11401866]


[71]

Betterle C, Presotto F, Furmaniak J. Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults. Journal of endocrinological investigation. 2019 Dec:42(12):1407-1433. doi: 10.1007/s40618-019-01079-6. Epub 2019 Jul 18     [PubMed PMID: 31321757]


[72]

Ngaosuwan K, Johnston DG, Godsland IF, Cox J, Majeed A, Quint JK, Oliver N, Robinson S. Increased Mortality Risk in Patients With Primary and Secondary Adrenal Insufficiency. The Journal of clinical endocrinology and metabolism. 2021 Jun 16:106(7):e2759-e2768. doi: 10.1210/clinem/dgab096. Epub     [PubMed PMID: 33596308]


[73]

Matsubayashi S, Nakatake N, Hara T. Possible adrenal insufficiency among fatigue patients in a psychosomatic medical clinic. Endocrine journal. 2020 Jan 28:67(1):53-57. doi: 10.1507/endocrj.EJ19-0096. Epub 2019 Oct 8     [PubMed PMID: 31597820]


[74]

White KG. A retrospective analysis of adrenal crisis in steroid-dependent patients: causes, frequency and outcomes. BMC endocrine disorders. 2019 Dec 2:19(1):129. doi: 10.1186/s12902-019-0459-z. Epub 2019 Dec 2     [PubMed PMID: 31791297]

Level 2 (mid-level) evidence

[75]

Woodcock T, Barker P, Daniel S, Fletcher S, Wass JAH, Tomlinson JW, Misra U, Dattani M, Arlt W, Vercueil A. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020 May:75(5):654-663. doi: 10.1111/anae.14963. Epub 2020 Feb 3     [PubMed PMID: 32017012]